Pfizer's Schneider To Boston Scientific: One Down, Two to Go
Executive Summary
The much-anticipated first shoe in Pfizer Inc.'s remaining three-legged device business finally fell with the sale of its Schneider Worldwide division to Boston Scientific Corp. The Schneider sale leaves Pfizer's orthopedics unit, Howmedica Inc., and urology company, American Medical Systems, on the block.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.